EverSource Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.27M	Buy	89,683 +32,218	+56%	+$1.7M	0.13%	132
2025 Q4	$3.01M	Sell	57,465 -39,969	-41%	-$2.39M	0.11%	152
2025 Q3	$6.31M	Buy	97,434 +4,491	+5%	+$258K	0.25%	85
2025 Q2	$4.52M	Buy	92,943 +8,063	+9%	+$312K	0.2%	102
2025 Q1	$2.89M	Buy	84,880 +84,708	+49,249%	+$3.59M	0.16%	119
2024 Q4	$6.77K	Sell	172 -1,308	-88%	-$61.8K	﹤0.01%	2198
2024 Q3	$69.5K	Sell	1,480 -1,092	-42%	-$55.4K	﹤0.01%	926
2024 Q2	$147K	Buy	2,572 +710	+38%	+$41.1K	0.01%	668
2024 Q1	$98.7K	Buy	1,862 +446	+31%	+$31.9K	0.01%	715
2023 Q4	$88.6K	Buy	1,416 +366	+35%	+$20.2K	0.01%	684
2023 Q3	$47.7K	Buy	1,050 +82	+8%	+$4.24K	0.01%	824
2023 Q2	$54.3K	Buy	968 +915	+1,726%	+$51.9K	0.01%	803
2023 Q1	$2.4K	Buy	53 +28	+112%	+$1.36K	﹤0.01%	1884
2022 Q4	$1.02K	Sell	25 -356	-93%	-$18.9K	﹤0.01%	2084
2022 Q3	$25K	Buy	381 +366	+2,440%	+$26.5K	0.01%	827
2022 Q2	$1K	Buy	+15	New	+$882	﹤0.01%	1622
2022 Q1	–	Sell	-34	Closed	-$3K	–	1732
2021 Q4	$3K	Buy	+34	New	+$2.97K	﹤0.01%	1405